title: Reversal of new oral anticoagulants.
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Battinelli
mesh_terms: D000925:Anticoagulants / Q000037:antagonists & inhibitors*; D000931:Antidotes / Q000494:pharmacology*; D001562:Benzimidazoles / Q000037:antagonists & inhibitors*; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000494:pharmacology*; D000069604:Dabigatran; D006801:Humans; D008297:Male; D009025:Morpholines / Q000037:antagonists & inhibitors*; D000069552:Rivaroxaban; D013876:Thiophenes / Q000037:antagonists & inhibitors*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D000931:Antidotes; D001562:Benzimidazoles; D001779:Blood Coagulation Factors; D009025:Morpholines; D013876:Thiophenes; D015091:beta-Alanine; C025667:prothrombin complex concentrates; D000069552:Rivaroxaban; D000069604:Dabigatran